A morbidity survey for chronic illness by the household interview technique.
Gill Js
Indian Journal of Public Health 26 ( 1) 53
1982
ON THE IONIZATION MEASUREMENTS AND THE PROCESS OF TRACK FORMATION IN NUCLEAR EMULSIONS
P.S. Gill , A.P. Sharma
Proc. Natl. Inst. Sci. India. Pt. A
1962
No Sex Please, We Are Indians
Gill
Indian Journal of Community Medicine 18 ( 1) 3
1993
Pharmacokinetics and biodistribution of humanized monoclonal antibody hu3S193 in a phase I trial of patients with advanced epithelial cancers which express the Lewis-gamma antigen
E Stockert , R Murphy , ID Davis , D MacGregor
Tissue Antigens 66 ( 5)
2005
Novel mRNA isoforms and mutations of uridine monophosphate synthetase and 5-fluorouracil resistance in colorectal cancer
Y-C Hou , O L Griffith , G S W Cheng , K Novik
Pharmacogenomics Journal 13 ( 2) 148 -158
20
2013
Hospital cost savings with transarterial radioembolization with yttrium-90 glass microspheres compared with transarterial chemoembolization in the management of hepatocellular carcinoma
M Hubert , A Karellis , M Sherman , S Gill
Journal of Vascular and Interventional Radiology 28 ( 2) S213
2017
PMS3 IMPROVEMENT IN EFFICACY AND SAFETY OUTCOMES AFTER CERVICAL ARTHROPLASTY VERSUS STANDARD ANTERIOR CERVICAL DISECTOMY AND FUSION (ACDF) SURGERIES:A META-ANALYSIS OF PUBLISHED RCTS
S Gill , A Maetzel , L Alvares , L Birinyi-Strachan
Value in Health 13 ( 7)
2010
A combined analysis of two prospective randomised studies exploring the impact of extended post-radiation temozolomide on survival outcomes in newly diagnosed glioblastoma
L Gately , C Mesía , JM Sepúlveda , S Del Barco
Journal of Neuro-Oncology 166 ( 3) 407 -415
2
2024
Exploring management and outcomes of elderly patients with glioblastoma using data from two randomised trials (GEINO1401/EX-TEM)
Lucy Gately , C Mesía , JM Sepúlveda , S Del Barco
Journal of Neuro-Oncology 1 -8
2024
Correction to: A combined analysis of two prospective randomised studies exploring the impact of extended post-radiation temozolomide on survival outcomes in newly diagnosed glioblastoma
L Gately , C Mesía , JM Sepúlveda , S Del Barco
Journal of neuro-oncology 166 ( 3) 417 -418
2024
Exploring the management of elderly patients with glioblastoma using data from GEINO14-01 and EX-TEM
L Gately , C Mesia , JM Sepulveda , S Del Barco
Journal of Geriatric Oncology 14 ( 8) S13 -S13
2023
Correlates of risk for disinhibited behaviors in the Million Veteran Program Cohort
Peter B Barr , Tim B Bigdeli , Jacquelyn L Meyers , Roseann E Peterson
JAMA psychiatry 81 ( 2) 188 -197
2024
Her2 Status in Gastric Adenocarcinoma: A Comparison of Immunohistochemistry (IHC), Fluorescent In-Situ Hybridization (FISH) and Dual Color Silver In-Situ Hybridization (SISH) Methods
C Zhou , D Huntsman , B Carter , T Thomson
LABORATORY INVESTIGATION 91 174A -174A
2011
Canadian Standardization of KRAS Mutation Testing in Metastatic Colorectal Carcinomas
T Zhang , S Gill , W Greer , D Huntsman
JOURNAL OF MOLECULAR DIAGNOSTICS 11 ( 6) 653 -653
2009
Penetrance and pleiotropy of polygenic risk scores for schizophrenia, bipolar disorder, and depression among adults in the US veterans affairs health care system
Tim B Bigdeli , Georgios Voloudakis , Peter B Barr , Bryan R Gorman
JAMA psychiatry 79 ( 11) 1092 -1101
3
2022
Re: Pooled analysis of fluorouracil-based adjuvant therapy of stage II and III colon cancer: Who benefits and by how much? Reply
SR Alberts , DJ Sargent , S Gill , CL Loprinzi
JOURNAL OF CLINICAL ONCOLOGY 23 ( 3) 654 -655
2005
How Long Have I Got? Can Time to Progression on Last Line Treatment Inform us About Post-Progression Survival Time in Advanced Gastric Cancer?
A Vasista , A Martin , N Pavlakis , K Sjoquist
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY 13 76 -76
2017
Update on the colon health and life-long exercise change (CHALLENGE) trial: A phase III study of the impact of an exercise program on disease-free survival in colon cancer survivors
KS Courneya , J Vardy , S Gill , D Jonker
Current Medicine Group
1
2014
ASCEND: a randomised, double-blinded, placebo-controlled, phase II study of gemcitabine and nab-paclitaxel with LSTA1 in untreated metastatic pancreatic adenocarcinoma. An Australasian Gastro-Intestinal Trials Group (AGITG) trial
J Lee , A Dean , T Price , K Sjoquist
ESMO Gastrointestinal Oncology 1 3 -8
1
2023
Phase I trial of the first-in-class agent CEND-1 in combination with gemcitabine and nab-paclitaxel in patients with metastatic pancreatic cancer
A Dean , S Gill , M McGregor , V Broadbridge
ANNALS OF ONCOLOGY 31 S941 -S941
1
2020